State-of-the-Art Mass Spectrometry Facility Advances Injury Biomarker Detection
8 Sept 2016
Find out how scientists at the Mass Spectrometry Center, University of Maryland (A Waters Center of Innovation), are using state-of-the-art facilities for drug discovery and development worldwide. Hear how the methods developed in the laboratory using instruments including the Waters’ SYNAPT G2-S mass spectrometer and MSE technology are helping to identify injury-related biomarkers that can be used in the development of therapeutics.
Related Products
Request Quote for All Products
SYNAPT G2-Si MS
WatersTransform your lab's discovery capability with the SYNAPT G2-Si MS. Information. Informatics. Impact. SYNAPT enables extensive characterization of complex mixtures and molecules with uncompromising qualitative and quantitative performance, streamlined workflows and unparalleled platform versatility. With the SYNAPT G2-Si you get ultimate UPLC/MS/MS performance, powerful data independent & data dependant solutions, CID and ETD fragmentation capabilities, and a wide range of experimental options.
